Science & Technology
The mosquito salivary protein AgBR1 as vaccine candidate against Chikungunya
Department of Health and Human Services — National Institutes of Health
Opportunity #: 1R41AI186794-01
Award Ceiling
$600K
Award Floor
$600K
Close Date
Jun 30, 2026
107 days leftTotal Funding
$600K
Expected Awards
1
Posted Date
Jul 17, 2024
Cost Sharing Required
No
Grants.gov ID
sbir-1R41AI186794-01
Description
STTR Phase Phase I award: "The mosquito salivary protein AgBR1 as vaccine candidate against Chikungunya" awarded to L2 DIAGNOSTICS LLC in NEW HAVEN, Connecticut. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $599,938. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.